Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AFM24 |
Synonyms | |
Therapy Description |
AFM24 is a bispecific antibody against EGFR and CD16A, which may result in an anti-tumor immune response, specifically, natural killer cells targeting tumor cells that express Egfr (J Clin Oncol 35, 2017 (suppl; abstr e14001)). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AFM24 | AFM-24|AFM 24 | EGFR Antibody 40 | AFM24 is a bispecific antibody against EGFR and CD16A, which may result in an anti-tumor immune response, specifically, natural killer cells targeting tumor cells that express Egfr (J Clin Oncol 35, 2017 (suppl; abstr e14001)). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04259450 | Phase Ib/II | AFM24 | Study to Assess AFM24 in Advanced Solid Cancers | Recruiting | USA | ESP | 2 |